ENTA- Enanta Pharmaceuticals Inc

Name: Enanta Pharmaceuticals Inc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Enanta Pharmaceuticals Inc (ENTA) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. ENTA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Luly Jay R.	858.0K	$13.16M	-
Other	Or Yat Sun	371.4K	$5.70M	-
Other	Luu Brendan	38.3K	$588.0K	-
Other	Kieffer Tara Lynn	30.6K	$469.7K	-
Other	Rottinghaus Scott T.	21.8K	$334.3K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Aug 20, 2018	Adda Nathalie80	Sr. VP &Chief Medical Officer	Sale+OE	4,155	$92.32	$383,596.16	-33.2%
Jul 18, 2018	Adda Nathalie80	Sr. VP &Chief Medical Officer	Sale+OE	5,045	$124.84	$629,842.67	-28.9%
Jul 6, 2018	Luly Jay R.71	President And CEO	Sell	35,000	$125.24	$4,383,459.58	-1.1%
Jun 18, 2018	Adda Nathalie80	Sr. VP &Chief Medical Officer	Sale+OE	4,155	$114.85	$477,222.20	-22.5%
Jun 11, 2018	Mellett Paul J63	Treasurer And CFO	Sell	15,000	$120.57	$1,808,523.06	-3.6%
May 17, 2018	Luly Jay R.71	President And CEO	Sell	25,000	$105.83	$2,645,654.89	-1.9%
May 16, 2018	Adda Nathalie80	Sr. VP &Chief Medical Officer	Sale+OE	4,155	$105.25	$437,333.12	-16.4%
Apr 16, 2018	Adda Nathalie80	Sr. VP &Chief Medical Officer	Sale+OE	4,225	$85.58	$361,559.68	-22.7%
Mar 19, 2018	Mellett Paul J63	Treasurer And CFO	Sell	9,000	$86.48	$778,330.51	-2.4%
Jan 4, 2017	Or Yat Sun59	Chief Scientific Officer	Sell	13,921	$35.09	$488,504.60	-4.4%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC